Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection

Abstract The effectiveness of COVID-19 vaccination in children and adolescents with prior SARS-CoV-2 infection remains unclear, particularly for Omicron subvariants. We evaluate vaccine effectiveness against reinfection with Omicron BA.1/BA.2, BA.4/BA.5, XBB, and later subvariants among 5- to 17-yea...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yuqing Lei, Jiajie Chen, Qiong Wu, Ting Zhou, Bingyu Zhang, Michael J. Becich, Yuriy Bisyuk, Saul Blecker, Elizabeth A. Chrischilles, Dimitri A. Christakis, Lindsay G. Cowell, Mollie R. Cummins, Soledad A. Fernandez, Daniel Fort, Sandy L. Gonzalez, Sharon J. Herring, Benjamin D. Horne, Carol Horowitz, Mei Liu, Susan Kim, Parsa Mirhaji, Abu Saleh Mohammad Mosa, Jennifer A. Muszynski, Catharine I. Paules, Alice I. Sato, Hayden T. Schwenk, Soumitra Sengupta, Srinivasan Suresh, Bradley W. Taylor, David A. Williams, Yongqun He, Jeffrey S. Morris, Ravi Jhaveri, Christopher B. Forrest, Yong Chen, On behalf of the RECOVER Consortium
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2026-04-01
Цуврал:	Nature Communications
Онлайн хандалт:	https://doi.org/10.1038/s41467-026-71820-2
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!